@article{16a9e6c985c14a05a829151ae69c4536,
title = "Combination of docetaxel, trastuzumab and pertuzumab or treatment with trastuzumab-emtansine for metastatic salivary duct carcinoma",
keywords = "Ado-trastuzumab emtansine, Docetaxel, Head and Neck Neoplasms, Neoplasm metastasis, Pertuzumab, Receptor, ErbB-2, Salivary duct carcinoma, Salivary gland neoplasms, Trastuzumab",
author = "\{van Boxtel\}, Wim and Eline Boon and Weijs, \{Willem L.J.\} and \{van den Hoogen\}, \{Frank J.A.\} and Flucke, \{Uta E.\} and \{Van Herpen\}, \{Carla M L\}",
note = "Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",
year = "2017",
month = sep,
doi = "10.1016/j.oraloncology.2017.06.023",
language = "English",
volume = "72",
pages = "198--200",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
}